ArticleKansas journal of medicine

Comparative Analysis of Reported Adverse Events with Nirsevimab and Palivizumab in the FAERS Database.

Ibrahim Touffaha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.